This profile describes access and programme structure. Inclusion is not an endorsement, regulatory finding, or clinical recommendation. Prescription decisions belong to a qualified prescriber.
At a glance
Pricing, medicine, location, care, fulfilment, funding, and policy claims are separated below.
An open check means the public sources were not specific enough—not that the service failed the check.
Resumen en español
Henry Meds para usuarios hispanohablantes
Esta sección ofrece una orientación breve en español sobre el perfil estadounidense. La investigación completa de precios, acceso, farmacia y seguimiento permanece arriba mientras ampliamos la revisión editorial en español.
No encontramos una fuente primaria suficientemente específica para afirmar que una cita clínica esté disponible en español. Confirma el idioma y cualquier servicio de interpretación antes de pagar.
- si la cita concreta será en español;
- el coste mensual ordinario y qué incluye;
- la licencia estatal del profesional;
- el medicamento, la farmacia y el coste por separado.
Esta traducción editorial no demuestra que el proveedor ofrezca atención clínica en español y no sustituye una valoración médica.
Comparar proveedores para hispanohablantes en EE. UU. →How the program is structured
A cash-pay program that presents one recurring bill for clinical review, compounded medication when prescribed, supplies, shipping, and ongoing care. Cancellation is flexible for monthly plans but multi-month terms can leave a balance due.
GLP.directory checked the cited public sources on Sep 13, 2026. We reviewed published access, cost, care, fulfilment, funding, cancellation, monitoring, and switching details; we have not audited individual clinical encounters, prescriptions, pharmacy operations, or outcomes.
Availability can change by state, clinician, medical history, product, pharmacy, inventory, and insurance plan. “Not publicly confirmed” means we did not find a sufficiently specific answer in the cited public material. Confirm the current patient-specific answer before paying or changing care.
Service configuration
These structured fields power the directory filters. They describe the reviewed public route and should be reconfirmed for the selected plan.
- Provider type
- Telehealth program
- Medicine context
- Semaglutide (Wegovy; Ozempic/Rybelsus for type 2 diabetes) · Tirzepatide (Zepbound; Mounjaro for type 2 diabetes)
- Formats reviewed
- Injection
- Funding routes
- Private pay
- Service features
- Clinician support · Switching pathway · Home delivery
- Access check
- Confirm current state access
- Evidence status
- Primary sources reviewed
- Research depth
- 2 cited sources · 2 medicine rows · 4 open checks
Recurring cost breakdown
- The advertised recurring bill includes provider review, medication and supplies when prescribed, shipping, and ongoing care.
- Insurance is not used.
- Monthly and longer-duration plans may be offered; longer plans must be evaluated by total obligation.
- Exact price varies by treatment page and should be confirmed at checkout.
- Medicine + dose
- Membership or consultation
- Delivery + supplies
- Labs + follow-up
- Renewal after offers
Medication and formulation matrix
| Medication | Form | Regulatory / program path | Published price view |
|---|---|---|---|
| Compounded semaglutide treatment | Injectable and other formulations as offered | Not FDA-approved | Treatment-page price; all-in structure advertised |
| Compounded tirzepatide treatment | Injectable as offered | Not FDA-approved | Treatment-page price; verify dose/term |
Important: “Compounded” means the product is not FDA approved. A brand approved for one condition is not automatically approved for another. The treating clinician determines whether any prescription is appropriate.
State-by-state availability
- Henry Meds operates in supported US states; a patient must use a clinician and pharmacy authorized for that location.
- Not every medication or consultation format is available in every state.
Clinician access and follow-up cadence
- Initial review can be by video or independent record review depending on state and treatment.
- Portal messaging and ongoing care are included.
- Confirm scheduled follow-up frequency and escalation access.
Pharmacy and fulfillment
- Medication is prepared and shipped by a partner pharmacy when prescribed.
- Typical shipping is advertised as eight to ten business days; California may take longer because of additional compound testing.
- The exact dispensing pharmacy should be confirmed from the order and label.
Insurance and prior authorization
- Cash-pay only; no insurance authorization is required for the reviewed compounded program.
- HSA/FSA reimbursement depends on the account administrator.
Cancellation, refund, and commitment
- Monthly service is advertised without a long-term contract and can be canceled through the portal, email, or phone.
- A multi-month plan may require payment of the remaining balance unless the terms allow a medical exception.
- Processed or shipped medication may not be refundable.
Labs, monitoring, and dose management
- A universal included lab panel is not part of the general all-in statement.
- The clinician can request tests based on history and treatment.
Maintenance and switching
- Ongoing care can support maintenance if clinically appropriate.
- Before switching, confirm whether the new clinician accepts the current formulation and dose and account for the published shipping window.
Program snapshot
All-in cash-pay program
Profiled support: Ongoing clinician access, Simplified intake and fulfillment.
Cash pay
The reviewed model is positioned as cash pay.
Verify before purchase
Compounded products are not FDA approved. Request the dispensing pharmacy and formulation details.
What the advertised program may include
- Telehealth assessment
- Clinician review
- Medication when prescribed
- Shipping as stated by the selected plan
Useful comparison signals
Based on the provider’s published program structure, this profile is tagged for the following searches. These are filters, not endorsements or clinical recommendations.
- Starting care and comparing first-provider requirements
- Switching providers or continuing an established treatment
- Comparing lower-cost access routes and recurring totals
- Ongoing clinician access
- Simplified intake and fulfillment
Open evidence gaps
These are material details we could not confirm precisely enough from the cited public pages. They are the highest-priority questions to resolve directly.
- One public state-by-product table
- Named pharmacy before checkout
- Universal lab protocol
- Fixed follow-up cadence
Questions to ask before paying
- What is the ordinary recurring total after any introductory period?
- Does that total include clinician care, medication, supplies, labs, and shipping?
- Which clinician group and dispensing pharmacy will be responsible for my care?
- What happens to billing if I am not prescribed the advertised treatment?
- What records and timing do you require if I am switching from another provider?
Source ledger
Every entry below is a provider-controlled or official public source. A source link documents what was published; it does not independently validate performance, regulatory compliance, safety, or outcomes.
Included-service model, consultation, shipping and cancellation overview
Billing, cancellation and multi-month obligations